BridgeBio Pharma, Inc. ($BBIO)
Filing Information
| Accession Number | 0001470831-26-000260 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 12, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
26,013
Total Value
$861,550.56
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 10, 2026 | Exercise/Conversion | 8,671 | $27.36 | $237,238.56 | 16,136 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 10, 2026 | Sale | 8,671 | $72.00 | $624,312.00 | 7,465 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Mar 10, 2026 | Exercise/Conversion | 8,671 | $0.00 | $0.00 | 17,343 | Direct | โ | View Details |